The European Union extends the approval period of 29 substances including abamectin
According to the Official Journal of the European Union, on March 4, 2022, the European Commission issued Regulation (EU) No. 2022/378 to extend the approval period of Abamectin and other 29 substances.
These substances include:
Abamectin,
Bacillus subtilis strain QST 713,
Bacillus thuringiensis subsp.aizawai strains ABTS-1857 and GC-91,
Bacillus thuringiensis subsp. israeliensis strain AM65-52,
Bacillus thuringiensis subsp. kurstaki strains ABTS 351, PB 54, SA 11, SA 12 and EG 2348,
Beauveria bassiana strain ATCC 74040 and GHA,
clodinafop
Cydia pomonella granulovirus,
Cyprodinil,
2,4-Dichlorprop-p,
Fenpyroximate,
fosetyl,
Malathion,
mepanipyrim,
metconazole,
metrafenone,
pirimicarb,
Pseudomonas chlororaphis strain MA 342,
Pyrimethanil,
Pythium oligandrum strain M1,
rimsulfuron,
spinosad,
Trichoderma asperellum strains ICC012, T25 and TV1,
richoderma atroviride strain T11,
Trichoderma gamsii strain ICC080,
Trichoderma harzianum strains T-22 and ITEM 908,
triclopyr
Trinexapac
Triticonazole
ziram
The approval period for the above substances will be extended to April 30, 2023.
